Market Tracker

09/02 6:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

4.96
Data as of Sep 02
 -0.10 / -1.98%
Today’s Change
4.40
Today|||52-Week Range
8.19
-18.29%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close5.06
Today’s open5.07
Day’s range4.95 - 5.07
Volume18,243
Average volume (3 months)69,759
Market cap$179.1M
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBIOEleven Biotherapeuti...+0.77+6.95%
EGRXEagle Pharmaceutical...-0.38-2.98%
DRRXDURECT Corp-0.03-1.90%
ATNMActinium Pharmaceuti...-0.13-2.09%
Data as of 4:00pm ET, 09/02/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts